| 7.79 0.09 (1.17%) | 09-17 13:05 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 9.28  |
1-year : | 10.84 |
| Resists | First : | 7.94 |
Second : | 9.28 |
| Pivot price | 7.41 |
|||
| Supports | First : | 7.02 |
Second : | 6.44 |
| MAs | MA(5) : | 7.7 |
MA(20) : | 7.2 |
| MA(100) : | 6.58 |
MA(250) : | 5.99 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 95.7 |
D(3) : | 94.8 |
| RSI | RSI(14): 69.3 |
|||
| 52-week | High : | 7.94 | Low : | 4.78 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MTLS ] has closed below upper band by 5.8%. Bollinger Bands are 20.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.74 - 7.77 | 7.77 - 7.8 |
| Low: | 7.54 - 7.57 | 7.57 - 7.6 |
| Close: | 7.64 - 7.7 | 7.7 - 7.75 |
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
Mon, 14 Sep 2026
Materialise (NASDAQ: MTLS) adds 43,345 shares to its buy-back - Stock Titan
Wed, 09 Sep 2026
Materialise NV (NASDAQ: MTLS) Executes Share Buyback Equal to 2.2% of Outstanding Shares - Kalkine Media
Tue, 08 Sep 2026
Materialise (NASDAQ: MTLS) has repurchased 2.2% of its shares so far - Stock Titan
Mon, 31 Aug 2026
Materialise: A High-Margin Medical Business Hiding In Plain Sight (NASDAQ:MTLS) - Seeking Alpha
Sun, 30 Aug 2026
Materialise NV (NASDAQ:MTLS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$8.92 - simplywall.st
Thu, 13 Aug 2026
Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026 - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Technology
|
|
|
Industry:
Software - Application
|
|
| Shares Out | 0 (M) |
| Shares Float | 58 (M) |
| Held by Insiders | 2.328e+007 (%) |
| Held by Institutions | 5.3 (%) |
| Shares Short | 399 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.27 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 595.59 |
| Profit Margin | 4.8 % |
| Operating Margin | 0.6 % |
| Return on Assets (ttm) | 1.6 % |
| Return on Equity (ttm) | 5.2 % |
| Qtrly Rev. Growth | 8.1 % |
| Gross Profit (p.s.) | 1.14794e+008 |
| Sales Per Share | 2.00566e+008 |
| EBITDA (p.s.) | 1.96544e+007 |
| Qtrly Earnings Growth | 1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 31 (M) |
| PE Ratio | 29.22 |
| PEG Ratio | 1.2 |
| Price to Book value | 0.01 |
| Price to Sales | 0 |
| Price to Cash Flow | 2.09 |
| Dividend | 0 |
| Forward Dividend | 399440 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|